documents: FDA-2015-N-1260-0003
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2015-N-1260-0003 | FDA | FDA-2015-N-1260 | Reference 8: Food and Drug Administration, Full Disclosure of Preliminary Regulatory Impact Analysis, Initial Regulatory Flexibility Analysis, and Unfunded Mandates Reform Act Analysis on Regulations on Fixed-Combination and Co-packaged Drugs and Combinations of Active Ingredients Under Consideration for Inclusion in an Over-the-Counter (OTC) Monograph Proposed Rule. | Supporting & Related Material | Background Material | 2015-12-23T05:00:00Z | 2015 | 12 | 2015-12-23T22:00:12Z | 0 | 0 | 0900006481dcf78a |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref